Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
/
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Accentis NV is a Belgium-based real estate company specializing in the ownership and management of industrial and semi-industrial properties, primarily in Belgium and Germany. Its core activities focus on maximizing portfolio value through optimizing recurrent rental income and implementing active portfolio and risk management strategies. The company's property portfolio, as of the end of 2024, encompasses a total area of 61,118 square meters with a market value of EUR 38.5 million, mainly comprising logistics and industrial assets. Operating with a lean team of approximately three to four employees, Accentis NV generates revenue predominantly from real estate operations, with sales concentrated in Belgium followed by contributions from Germany and historically Slovakia. Headquartered in Antwerp at Noorderlaan 139, the firm was founded in 1994 and maintains a long-term approach to enhancing asset performance in the real estate services sector. Key executives include CEO Bruno Holthof, who also serves as Acting Executive Chairman, alongside CFO Evelien Devlieger and other specialized managers.
€0.03
+€0.00 (+0.00%)
EOD Jun 23, 2026 · Twelve Data
59.17% operating margin is above average. ROIC at 5.33%. Note that capital returns lag the margin, the business may be capital-intensive despite high margins.
Revenue declined 9.4% YoY. Margins deteriorated 3.5pp alongside, both lines moving the wrong way.
At 28x earnings, the current multiple leaves limited room for execution misses or growth deceleration. Free cash flow declined 24% versus the prior year, cash generation momentum has weakened.
27.5x earnings, 11.4x FCF. Not cheap, the quality is already reflected in the price. Upside from here requires either margin expansion or growth re-acceleration, not just continuation.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
€6M
▼ -9.4% YoY
Net Income (TTM)
€1M
▲ +59.1% YoY
Op. Margin
59.17%
▼ -3.5pp YoY
ROIC
5.33%
▲ +0.3pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
€3M
▼ -23.8% YoY
Op. Cash Flow (TTM)
€3M
▼ -23.7% YoY
Net Debt
-€12M
Net Cash Position
Cash & Equiv.
€22M
3Y CAGR: -8.7%
3Y CAGR: +3.3%
Continue Research
At a P/E of 27.5 and a price-to-free-cash-flow of 11.4, Accentis NV (ACCB.XBRU) trades below a two-stage DCF intrinsic value of about €0.05 per share, so at €0.03 the stock looks undervalued (87.1% below estimated intrinsic value). A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Accentis NV scores 60/100 on Intrinsiqq's quality scorecard (a solid business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from SEC filings; read the full methodology. This is analysis, not investment advice.
Intrinsiqq's two-stage DCF estimates an intrinsic value of about €0.05 per share for ACCB.XBRU, projecting its recent free cash flow forward with a growth rate that fades toward a long-run rate and discounting it back to today. Applying a 25% margin of safety gives a more conservative fair-value entry around €0.04. At today's €0.03, that puts the stock about 87.1% below estimated intrinsic value. The result is sensitive to the growth and discount-rate inputs, so it is best to run conservative, base and optimistic cases. You can adjust all of them yourself with the sliders on the DCF tab.
Accentis NV scores 60 out of 100 on Intrinsiqq's quality score, passing 3 of 8 checks, which makes it a solid business on these measures. Recent fundamentals include a 59.2% operating margin and a 5.3% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full check-by-check breakdown is on the quality scorecard.
That depends on valuation and quality together, not either alone. ACCB.XBRU currently trades below its estimated intrinsic value and scores 60/100 on quality (solid). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.